SCHEMBL4838615

SCHEMBL4838615

CCCc1ccc(C(=O)Nc2ccc(C(=O)/C=C3\NC(C)(C)Cc4ccc(OC)cc43)cc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 2/20 0.49
ENPP1 P22413 1/20 0.41
CCR5 P51681 2/20 0.41
MCHR1 Q99705 1/20 0.41
KDM4E B2RXH2 3/20 0.40
LMNA P02545 1/20 0.40
ALDH1A1 P00352 3/20 0.40
NPC1 O15118 2/20 0.40
CYP1A2 P05177 2/20 0.40
TP53 P04637 1/20 0.40
ALOX15 P16050 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
MAPT P10636 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
NAMPT P43490 1/20 0.40
HPGD P15428 2/20 0.39
PLK1 P53350 1/20 0.39
PLK3 Q9H4B4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4838623 1.00 ABCG2 (0.49) ABCG2ENPP1CCR5MCHR1KDM4E
SCHEMBL4834977 0.95 KDM4E (0.44) ABCG2CCR5KDM4ELMNAALDH1A1
SCHEMBL4834983 0.95 KDM4E (0.44) ABCG2CCR5KDM4ELMNAALDH1A1
SCHEMBL4837503 0.94 PLK1 (0.47) ABCG2CCR5KDM4ELMNAALDH1A1
SCHEMBL4837494 0.94 PLK1 (0.47) ABCG2CCR5KDM4ELMNAALDH1A1
SCHEMBL4844736 0.94 PLK1 (0.48) ABCG2CCR5KDM4ENAMPTPLK1
SCHEMBL4844715 0.94 PLK1 (0.48) ABCG2CCR5KDM4ENAMPTPLK1
SCHEMBL4835308 0.93 KCNA5 (0.41) ABCG2KDM4ELMNAALDH1A1NPC1
SCHEMBL4835293 0.93 KCNA5 (0.41) ABCG2KDM4ELMNAALDH1A1NPC1
SCHEMBL4844038 0.92 ABCG2 (0.45) ABCG2KDM4ELMNAALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7378428-B2 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2008-05-27 US disclosed
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2005-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient PARK7, MMP8, CDK7 ABCG2 4483/4885ENPP1 600/4885CCR5 256/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.